Sunday, April 20, 2014
Inquirer Daily News

Pharma business model broken, survey says

Nearly 70 percent of pharmaceutical leaders say that the business model for companies selling drugs is broken and needs remodeling, according to a survey conducted by Booz & Co., and Philadelphia's National Analysts Worldwide.

Pharma business model broken, survey says

Nearly 70 percent of pharmaceutical leaders say that the business model for companies selling drugs is broken and needs remodeling, according to a survey conducted by Booz & Co., and Philadelphia's National Analysts Worldwide.

The biggest challenge facing pharma companies is pricing pressure brought on by governments facing tight budgets. The logical next biggest challenge is the need to justify why a drug is better than the industry standard.

The full survey report is here.

David Sell
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

For Inquirer.com. Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at dsell@phillynews.com.

David Sell
Latest Health Videos
Also on Philly.com:
Stay Connected